Trending Topic

6 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Grace Johanna Salazar Tamayo

Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control can only be achieved with various measures applied continuously and consistently by a group of […]

Carlos Chaccour, ISNTD d3 2021: Ivermectin for COVID-19

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 22nd 2021

It was a delight to be able to speak with Dr Carlos Chaccour (University of Barcelona, Barcelona, Spain) about the controversy currently surrounding the use of ivermectin for the treatment of COVID-19.

His presentation entitled Ivermectin and COVID: what’s going on?  was presented at the ISNTD d3 2021 Virtual Congress, 24-25 February.

Questions:

  1. Could you give us a brief overview of the controversy surrounding the use of ivermectin for the treatment of COVID-19? (0:49)
  2. What evidence has been generated to date to help support the case for and against the drug’s use? (3:53)
  3. What further evidence is emerging on the efficacy of ivermectin in this indication? (6:36)

Disclosures: Dr Carlos Chaccour has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media

Filmed in coverage of ISNTD d3 2021 Virtual Conference.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup